FMC Corporation Announces Fourth Quarter 2007 Results and Outlook for 2008

- Record fourth quarter operating results with segment earnings up 40 percent

PHILADELPHIA, Feb. 6 /PRNewswire-FirstCall/ -- FMC Corporation (NYSE: FMC)
today reported net income of $40.9 million, or $0.53 per diluted share, in the
fourth quarter of 2007, versus net income of $12.2 million, or $0.16 per
diluted share, in the fourth quarter of 2006. Net income in the current
quarter included restructuring and other income and charges of $4.3 million
after-tax, or charges of $0.06 per diluted share, versus restructuring and
other income and charges of $35.6 million after-tax, or charges of $0.45 per
diluted share, in the prior-year quarter. Excluding these items, the company
earned $0.59 per diluted share in the current quarter versus $0.61 per diluted
share in the fourth quarter of 2006. Fourth quarter revenue of $674.3 million
increased 15 percent versus $587.3 million in the prior year.
William G. Walter, FMC chairman, president and chief executive officer,
said, "All of our businesses delivered outstanding results in the fourth
quarter, enabling us to finish our fourth straight record year for the
company. Agricultural Products achieved sales gains across Asia and Latin
America and once again benefited from supply chain productivity improvements.
Specialty Chemicals realized higher volumes and selling prices in lithium and
strong commercial performance in BioPolymer. Industrial Chemicals
demonstrated robust operating momentum, driven by higher selling prices in
soda ash, volume growth across the segment and improved power market
conditions in Spain."
Revenue in Agricultural Products of $229.5 million was 18 percent higher
than the prior-year quarter. Sales gains were achieved across Asia and Latin
America, particularly in Brazil driven by robust agrochemical market
conditions. Segment earnings before interest and taxes ("segment earnings")
of $31.9 million were up 44 percent versus the year-ago quarter, driven by the
higher sales and continued global supply chain productivity improvements.
Revenue in Specialty Chemicals was $161.0 million, an increase of 10
percent versus the prior-year quarter, due to higher volumes and selling
prices in lithium and strong commercial performance in BioPolymer. Segment
earnings of $34.1 million increased 39 percent versus the year-ago quarter, as
a result of the higher sales and continued manufacturing productivity
improvements, partially offset by higher raw material costs.
Revenue in Industrial Chemicals was $284.5 million, an increase of 15
percent from the prior-year quarter, driven by higher selling prices for soda
ash, volume growth across the segment and favorable currency translation.
Segment earnings of $28.8 million increased 36 percent versus the year-ago
quarter, as higher sales and improved power market conditions in Spain more
than offset higher raw material and energy costs.
Corporate expense was $12.8 million, up from $12.4 million in the prior-
year quarter. Other Income (Expense) was an expense of $3.1 million versus
income of $11.5 million prior-year quarter, driven by lower LIFO income. Book
tax rate on earnings before restructuring and other income and charges was
36.3 percent compared to 19.1 percent in the prior-year quarter. Taken
together, the higher book tax rate and lower LIFO income unfavorably impacted
earnings before restructuring and other income and charges by $0.28 per
diluted share compared to the prior-year quarter. Interest expense, net, was
$7.9 million as compared to $7.8 million in the year-ago quarter. On December
31, 2007, gross consolidated debt was $545.2 million, and debt, net of cash,
was $469.7 million. For the quarter, depreciation and amortization was $33.0
million and capital expenditures were $38.9 million.
Full Year 2007 Results
Revenue was $2,632.9 million, an increase of 12 percent versus $2,345.9
million in the prior year. Net income was $132.4 million, or $1.71 per
diluted share, as compared to $131.3 million, or $1.66 per diluted share, in
the prior year. Net income in 2007 included restructuring and other income
and charges of $107.3 million, or charges of $1.38 per diluted share versus
restructuring and other income and charges of $84.4 million, or charges of
$1.07 per diluted share in 2006. Excluding these items, the company earned
$239.7 million, or $3.09 per diluted share for the full year 2007, versus
$215.7 million, or $2.73 per diluted share, for the full year 2006.
Revenue in Agricultural Products was $889.7 million, an increase of 16
percent versus the prior year. Higher sales were realized in all geographic
regions, but were particularly strong in Brazil due to increased planted acres
in key crops and higher commodity prices. Sales growth in Europe was driven
by increased demand for bio-fuels crops, new product introductions and the
benefit of the stronger euro. In Asia, sales increased due to better growing
conditions in several countries. Segment earnings of $207.0 million increased
38 percent versus the prior year as a result of the higher sales and continued
global supply chain productivity improvements, which more than offset higher
incremental selling and distribution costs due to the increased sales and
higher raw material and energy costs.
Revenue in Specialty Chemicals was $659.5 million, an increase of 11
percent versus the prior year, driven by higher selling prices for primary
lithium compounds and strong commercial performance in both pharmaceutical and
food businesses in BioPolymer. Segment earnings of $142.7 million increased
20 percent versus the prior year due to higher sales, improved mix and
continued productivity improvements, which more than offset increased raw
material costs.
Revenue in Industrial Chemicals was $1,087.1 million, an increase of 10
percent versus the prior year, as a result of higher selling prices for soda
ash and volume growth across the segment. Segment earnings of $92.5 million
decreased 4 percent versus the prior year, as higher energy and raw material
costs across the segment and lower electricity selling prices in Spain in the
first three quarters of the year more than offset the positive impact of
higher sales.
Corporate expense was $52.3 million, as compared to $46.2 million in 2006.
Other Income (Expense) was an expense of $12.0 million versus income of $3.0
million in the prior year, driven by lower LIFO income. Interest expense,
net, was $34.9 million, up from $32.9 million in the prior year. Book tax
rate on earnings before restructuring and other charges was 30.1 percent
compared to 25.4 percent in the prior year. For the year, depreciation and
amortization was $133.7 million and capital expenditures were $115.4 million.
Outlook
Regarding the outlook for 2008, Walter said, "We expect another record
year in 2008 with earnings before restructuring and other income and charges
of $3.80 to $4.00 per diluted share. Industrial Chemicals carries strong
operating momentum into the new year and should benefit from continued volume
growth, higher pricing levels and improved power market conditions in Spain.
We look for further growth in Agricultural Products through the successful
application of its focused strategy, new product introductions and additional
global supply chain productivity improvements. In Specialty Chemicals,
earnings growth will be driven by strong commercial performance in BioPolymer
and continued productivity improvements across the segment. We expect to
achieve these results despite the headwinds of higher raw material costs
across our businesses. We will derive significant benefit in 2008 from our
global footprint, the non-cyclical nature of our end-use markets and our
limited exposure to rising petrochemical costs."
Walter added, "For the first quarter of 2008, we expect earnings before
restructuring and other income and charges of $1.15 to $1.20 per diluted
share, driven by double-digit earnings growth in all operating segments of our
company."
FMC will conduct its fourth quarter conference call and webcast at 11:00
a.m. ET on Thursday, February 7, 2008. This event will be available live and
as a replay on the web at www.fmc.com. Prior to the conference call,
the Company will also provide supplemental information on the web including
its 2008 Outlook Statement, definitions of non-GAAP terms and reconciliations
of non-GAAP figures to the nearest available GAAP term.
FMC Corporation is a diversified chemical company serving agricultural,
industrial and consumer markets globally for more than a century with
innovative solutions, applications and quality products. The company employs
over 5,000 people throughout the world. The company operates its businesses
in three segments: Agricultural Products, Specialty Chemicals and Industrial
Chemicals.
Safe Harbor Statement under the Private Securities Act of 1995: Statements
in this news release that are forward-looking statements are subject to
various risks and uncertainties concerning specific factors described in FMC
Corporation's 2006 Form 10-K and other SEC filings. Such information
contained herein represents management's best judgment as of the date hereof
based on information currently available. FMC Corporation does not intend to
update this information and disclaims any legal obligation to the contrary.
Historical information is not necessarily indicative of future performance.

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in millions, except per share amounts)

Three Months Ended Twelve Months Ended
December 31, December 31,
2007 2006 2007 2006

Revenue $674.3 $587.3 $2,632.9 $2,345.9

Costs of sales and services 478.7 415.6 1,830.1 1,636.5
Selling, general and administrative
expenses 86.2 77.4 315.3 284.9
Research and development expenses 27.2 26.7 94.6 96.9
In-process research and development - - 2.0 2.0
Restructuring and other charges 22.9 7.2 162.9 74.8

Total costs and expenses 615.0 526.9 2,404.9 2,095.1

Income from operations 59.3 60.4 228.0 250.8

Equity in (earnings) loss of affiliates (0.2) (0.6) (2.5) (2.3)
Minority interests 3.5 1.3 9.6 7.8
Interest expense, net 7.9 7.8 34.9 32.9
Loss on extinguishment of debt - - 0.3 -

Income from continuing operations
before income taxes 48.1 51.9 185.7 212.4

Provision for income taxes 2.2 20.0 29.0 68.3

Income from continuing operations 45.9 31.9 156.7 144.1
Discontinued operations, net of income
taxes (5.0) (19.7) (24.3) (12.8)

Net income $40.9 $12.2 $132.4 $131.3

Basic earnings (loss) per common share:

Continuing operations $0.62 $0.42 $2.08 $1.88
Discontinued operations (0.07) (0.26) (0.32) (0.17)

Basic earnings per common share $0.55 $0.16 $1.76 $1.71

Average number of shares used in basic
earnings per share computations 74.8 75.9 75.4 76.6

Diluted earnings (loss) per common share:
Continuing operations $0.59 $0.41 $2.02 $1.82
Discontinued operations (0.06) (0.25) (0.31) (0.16)

Diluted earnings per common share $0.53 $0.16 $1.71 $1.66

Average number of shares used in diluted
earnings per share computations 77.1 78.3 77.6 79.1

Other Data:
Capital expenditures $38.9 $35.1 $115.4 $115.6
Depreciation and amortization expense $33.0 $33.8 $133.7 $131.8

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME FROM CONTINUING OPERATIONS,
EXCLUDING RESTRUCTURING AND OTHER INCOME AND CHARGES (NON-GAAP)*
(Unaudited, in millions, except per share amounts)

Three Months Ended Twelve Months Ended
December 31, December 31,
2007 2006 2007 2006

Revenue $674.3 $587.3 $2,632.9 $2,345.9

Costs of sales and services 478.7 415.6 1,836.2 1,636.5
Selling, general and administrative
expenses 86.2 77.4 315.3 284.9
Research and development expenses 27.2 26.7 94.6 96.9

Total costs and expenses 592.1 519.7 2,246.1 2,018.3

Income from operations 82.2 67.6 386.8 327.6

Equity in (earnings) loss of affiliates (0.2) (0.6) (2.1) (2.3)
Minority interests 3.5 1.3 11.0 7.8
Interest expense, net 7.9 7.8 34.9 32.9

Income from continuing operations before
income taxes, excluding restructuring
and other income and charges 71.0 59.1 343.0 289.2

Provision for income taxes 25.8 11.3 103.3 73.5

After-tax income from continuing
operations, excluding restructuring
and other income and charges * $45.2 $47.8 $239.7 $215.7

Basic after-tax income from continuing
operations per share, excluding
restructuring and other income and
charges $0.60 $0.63 $3.18 $2.82

Average number of shares used in basic
after-tax income per share
computations 74.8 75.9 75.4 76.6

Diluted after-tax income from
continuing operations per share,
excluding restructuring and other
income and charges $0.59 $0.61 $3.09 $2.73

Average number of shares used in
diluted after-tax income per share
computations 77.1 78.3 77.6 79.1

* The Company believes that the Non-GAAP financial measure "After-tax
income from continuing operations, excluding restructuring and other
income and charges," and its presentation on a per share basis, provides
useful information about the Company's operating results to investors and
securities analysts. The Company also believes that excluding the effect
of restructuring and other income and charges from operating results
allows management and investors to compare more easily the financial
performance of its underlying businesses from period to period.

See attachment 3 of 6 for the reconciliation of Non-GAAP financial
measures to GAAP financial results.

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
RECONCILIATION OF NET INCOME (GAAP) TO AFTER-TAX INCOME FROM CONTINUING
OPERATIONS, EXCLUDING RESTRUCTURING AND OTHER INCOME AND CHARGES (NON-GAAP)
(Unaudited, in millions, except per share amounts)

Three Months Twelve Months
Ended Ended
December 31, December 31,
2007 2006 2007 2006

Net income (GAAP) $40.9 $12.2 $132.4 $131.3

Discontinued operations, net of
income taxes (a) 5.0 19.7 24.3 12.8

Restructuring and other (income)
charges, net (b) 22.9 7.2 155.0 74.8

In-process research and development (c) - - 2.0 2.0

Loss on extinguishment of debt (d) - - 0.3 -

Tax effect of restructuring and other
(income) charges, in-process
research and development, and loss
on extinguishment of debt (8.5) (2.4) (58.9) (17.7)

Tax adjustments (e) (15.1) 11.1 (15.4) 12.5

After-tax income from continuing
operations, excluding restructuring
and other income and charges
(Non-GAAP) $45.2 $47.8 $239.7 $215.7

Diluted earnings per common share
(GAAP) $0.53 $0.16 $1.71 $1.66

Discontinued operations per diluted
share 0.06 0.25 0.31 0.16

Restructuring and other (income)
charges, net per diluted share,
before tax 0.30 0.09 2.00 0.94

In-process research and development
per diluted share, before tax - - 0.03 0.03

Loss on extinguishment of debt per
diluted share, before tax - - 0.01 -
Tax effect of restructuring and other
(income) charges, in-process
research and development and loss on
extinguishment of debt (0.10) (0.03) (0.76) (0.22)

Tax adjustments per diluted share (0.20) 0.14 (0.21) 0.16

Diluted after-tax income from
continuing operations per share,
excluding restructuring and other
income and charges (Non-GAAP) $0.59 $0.61 $3.09 $2.73

Average number of shares used in
diluted after-tax income from
continuing operations per share
computations 77.1 78.3 77.6 79.1

(a) Discontinued operations for the three and twelve months ended
December 31, 2007 as well as the three and twelve months ended December
31, 2006 primarily includes provision for environmental liabilities and
legal reserves and expenses related to previously discontinued
operations. Partially offsetting the provision for the twelve months
ended December 31, 2006 is gain from sale of land locations in San
Jose, California to the City of San Jose of $14.0 million. The land
sale completed the sale of land that was formerly used by our defense
business, which we divested in 1997.

(b) 2007
Amounts for the three months ended December 31, 2007 primarily
include continued charges related to the closure of our Baltimore
agricultural chemicals facility ($15.0 million), charges associated
with continuing environmental sites as a Corporate charge ($4.0
million) and severance charges in our Industrial Chemicals segment
($1.8 million).

For the twelve months ended December 31, 2007, amounts primarily
include charges related to the closure of our Baltimore facility
($104.9 million), charges associated with the asset abandonment of one
of our Foret cogeneration facilities which is part of our Industrial
Chemicals segment ($8.2 million before minority interest) and charges
related to the settlement of all claims with Solutia and Astaris (now
known as Siratsa) regarding our contribution of PPA technology to the
Astaris joint venture in our Industrial Chemicals segment ($22.5
million). Remaining charges for the twelve months ended December 31,
2007 primarily include the Foret impairment charges due to the
commitment to the abandonment of certain fixed assets ($4.0 million) as
well as charges associated with continuing environmental sites as a
Corporate charge ($10.2 million) and severance costs ($6.8 million)
primarily in our Industrial Chemicals segment.

In addition to the line item "Restructuring and other charges" as
presented in the condensed consolidated statements of operations and
discussed in detail above, the line item in the above reconciliation
includes the following:

- A $0.4 million gain related to cash received from our Astaris joint
venture whose assets were substantially sold in 2005. On the condensed
consolidated statements of operations this gain is included in "Equity
in (earnings) loss of affiliates" for the twelve months ended
December 31, 2007.

- Minority interest of $1.4 million related to the abandonment of one
of our Foret co-generation facilities as previously discussed above.
We own 75% of this entity. The minority interest is included in
"Minority interests" in the condensed consolidated statements of
operations for the twelve months ended December 31, 2007.

- A non-cash gain of $6.1 million related to an adjustment to our
last in, first out (LIFO) inventory reserves as a result of a
correction in determining our initial LIFO inventory base year. This
gain was recorded to "Costs of sales and services" for the twelve
months ended December 31, 2007 in the condensed consolidated
statements of operations.

2006
Amounts for the three months ended December 31, 2006 primarily
include environmental reserve adjustments for our continuing
environmental sites ($4.5 million), and severance costs in our
Specialty Chemicals segment due to a workforce restructuring ($1.3
million). For the twelve months ended December 31, 2006 amounts
primarily include charges related to the settlement of an antitrust
class action involving our microcrystalline cellulose product in our
Specialty Chemicals segment ($25.7 million), abandonment of a building
at one of our manufacturing locations in our Agricultural Products
segment ($6.0 million) and asset abandonment and severance charges
related to workforce reductions at our Princeton, New Jersey R&D
facility ($5.3 million) also in our Agricultural Products segment, and
a charge of €25 million (US$30 million) related to a fine imposed on us
by the European Commission as a result of alleged violations of
competition law in the hydrogen peroxide business in Europe prior to
2000. This fine is associated with our Industrial Chemicals segment. We
have appealed the decision of the European Commission.

(c) Proprietary Fungicide Agreement
In the second quarter of 2006, our Agricultural Products segment entered
into agreements in which we were granted an initial right to further
develop a third party's proprietary fungicide in certain geographic
markets. Under those agreements, we paid $2.0 million and recorded the
amount as a charge to "In-process research and development" in the
condensed consolidated statement of operations for the twelve months ended
December 31, 2006.

In the first quarter of 2007, our Agricultural Products segment
acquired further rights from this third-party company to develop their
proprietary fungicide. In acquiring those further rights, we paid an
additional $1.0 million and have recorded this amount as a charge to
"In-process research and development" in the condensed consolidated
statement of operations for the twelve months ended December 31, 2007.

Collaboration and License Agreement
In the third quarter of 2007, our Agricultural Products segment entered
into a collaboration and license agreement with a third-party company
for the purpose of obtaining certain technology and intellectual
property rights. We paid an initial $1.0 million upon entering into
this agreement and have recorded the amount as a charge to "In-process
research and development" in the condensed consolidated statement of
operations for twelve months ended December 31, 2007.

(d) Amount for the twelve months ended December 31, 2007 represents
loss on the early extinguishment of debt related to the Domestic credit
agreement which replaced the 2005 credit agreement. The loss
represents the write-off of deferred financing fees associated with our
previous credit agreements.

(e) Tax adjustments for the three and twelve months ended December 31,
2007 primarily include tax benefits related to the reversal of certain
tax valuation allowances. These allowances are no longer necessary
because of our expectation that the related deferred tax assets are now
likely to be realized. Partially offsetting these valuation
adjustments are charges associated with adjustments to deferred income
taxes and other adjustments related to prior year tax matters.

Tax adjustments for the three and twelve months ended December 31, 2006
primarily represent charges associated with adjustments to deferred
income taxes and other adjustments related to prior year tax matters.

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
INDUSTRY SEGMENT DATA
(Unaudited, in millions)

Three Months Ended Twelve Months Ended
December 31, December 31,
2007 2006 2007 2006

Revenue

Agricultural Products $229.5 $194.5 $889.7 $765.9
Specialty Chemicals 161.0 146.0 659.5 592.8
Industrial Chemicals 284.5 247.7 1,087.1 990.9
Eliminations (0.7) (0.9) (3.4) (3.7)

Total $674.3 $587.3 $2,632.9 $2,345.9

Income from continuing operations
before income taxes

Agricultural Products $31.9 $22.1 $207.0 $149.9
Specialty Chemicals 34.1 24.5 142.7 118.8
Industrial Chemicals 28.8 21.2 92.5 96.7
Eliminations - - - (0.1)

Segment operating profit 94.8 67.8 442.2 365.3
Corporate (12.8) (12.4) (52.3) (46.2)
Other income (expense), net (3.1) 11.5 (12.0) 3.0

Operating profit from continuing
operations before items noted below: 78.9 66.9 377.9 322.1

Restructuring and other income
(charges), net (a) (22.9) (7.2) (155.0) (74.8)
Interest expense, net (7.9) (7.8) (34.9) (32.9)
In-process research and development (b) - - (2.0) (2.0)
Loss on extinguishment of debt (c) - - (0.3) -

Income from continuing operations
before income taxes $48.1 $51.9 $185.7 $212.4

(a) Amounts for the three months ended December 31, 2007 related to
Agricultural Products ($15.0 million), Industrial Chemicals ($2.7
million), Specialty Chemicals ($1.2 million) and Corporate ($4.0 million).
Amounts for the three months ended December 31, 2006 related to Specialty
Chemicals ($2.2 million), Industrial Chemicals ($0.5 million) and
Corporate ($4.5 million).

Amounts for the twelve months ended December 31, 2007 related to
Agricultural Products ($106.3 million), Industrial Chemicals
($41.5 million), Specialty Chemicals ($3.1 million) and
Corporate ($4.1 million). Amounts for the twelve months ended December
31, 2006 related to Industrial Chemicals ($31.9 million), Specialty
Chemicals ($26.3 million), Agricultural Products ($11.4 million) and
Corporate ($5.2 million).

See Note B to the schedule "Reconciliation of Net Income (GAAP) to After-
Tax Income from Continuing Operations Excluding Restructuring and Other
Income and Charges (Non-GAAP)" for further details on the components that
make up this line item.

(b) See Note C to the schedule "Reconciliation of Net Income (GAAP) to
After-Tax Income from Continuing Operations Excluding Restructuring and
Other Income and Charges (Non-GAAP)" for further details on the components
that make up this line item.

(c) Amount for the twelve months ended December 31, 2007 represents loss
on the early extinguishment of debt related to the Domestic credit
agreement which replaced the 2005 credit agreement. The loss represents
the write-off of deferred financing fees associated with our previous
credit agreements.

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in millions)

December 31, December 31,
2007 2006

Cash and cash equivalents $75.5 $165.5
Trade receivables, net 599.7 537.9
Inventories 275.0 219.4
Other current assets 126.9 91.3
Deferred income taxes 117.0 53.7
Total current assets 1,194.1 1,067.8

Property, plant and equipment, net 934.7 1,025.1
Goodwill 180.2 163.6
Deferred income taxes 259.0 336.5
Other long - term assets 165.4 147.7
Total assets $2,733.4 $2,740.7

Short - term debt $47.9 $53.7
Current portion of long - term debt 77.7 52.5
Accounts payable, trade and other 327.4 301.4
Guarantees of vendor financing 29.7 25.6
Accrued pensions and other post-retirement
benefits, current 10.6 7.5
Other current liabilities 258.1 276.8
Total current liabilities 751.4 717.5

Long-term debt 419.6 523.5
Long-term liabilities 498.1 489.5
Stockholders' equity 1,064.3 1,010.2
Total liabilities and stockholders' equity $2,733.4 $2,740.7

FMC CORPORATION AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Unaudited, in millions)

Twelve Months Ended
December 31,
2007 2006

Cash provided by operating activities $314.7 $307.2

Cash (required) by operating activities
of discontinued operations (45.1) (43.2)

Cash provided (required) by investing activities:
Capital expenditures (115.4) (115.6)
Other investing activities (5.2) 5.8
(120.6) (109.8)

Cash provided (required) by financing activities:
Increase (decrease) in short-term debt (5.1) (27.1)
Financing fees (0.7) -
Repayment of long-term debt (95.9) (91.5)
Distributions to minority partners (10.2) (7.3)
Dividends paid (29.7) (21.0)
Repurchases of common stock (116.4) (92.2)
Issuances of common stock, net 14.6 40.6
(243.4) (198.5)

Effect of exchange rate changes on cash 4.4 3.4

Increase (decrease) in cash and cash
equivalents (90.0) (40.9)

Cash and cash equivalents, beginning of year 165.5 206.4

Cash and cash equivalents, end of period $75.5 $165.5

SOURCE FMC Corporation

Media, Jim Fitzwater, +1-215-299-6633, or Investor Relations, Brennen Arndt,
+1-215-299-6266, both of FMC Corporation